Roivant Sciences is a global healthcare company focused on realizing the full value of promising biomedical research to improve the lives of patients and their families. We deliver R&D solutions to our partners in the biopharmaceutical industry, helping them unlock value from their pipelines by completing the clinical development of promising drug candidates. Our pipeline spans multiple therapeutic areas through partnerships with academic institutions and biopharmaceutical companies, including Takeda, Merck, GlaxoSmithKline, AstraZeneca, Vertex, Eisai, HanAll, Ligand, Poxel, Oxford BioMedica, Arena, Portola, Duke University, Mount Sinai, and Cincinnati Children’s Hospital Medical Center.